Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations

Jack E. Henningfield, Sandra D. Comer, Matthew L. Banks, Marion A. Coe, Gregory T. Collins, Ziva D. Cooper, William E. Fantegrossi, Caitlyn J. Durgin, David J. Heal, Sally L. Huskinson, Ryan K. Lanier, Wendy J. Lynch, Richard A. Meisch, James K. Rowlett, Justin C. Strickland, Brenda M. Gannon

Journal of Psychopharmacology

Published online on November 04, 2025

Abstract

Journal of Psychopharmacology, Ahead of Print.
Introduction:Abuse potential assessment of drugs with central nervous system activity is a critical component of the development of new medications for regulatory filings for approval worldwide. These new drug applications typically include ...